These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21434875)

  • 21. The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: a post hoc analysis of combined clinical trials.
    Tomson T; Almas M; Giordano S; Cabrera J
    Epilepsy Res; 2011 Sep; 96(1-2):64-73. PubMed ID: 21624821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective audit of adjunctive zonisamide in an everyday clinical setting.
    Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ
    Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin: a new antiepileptic drug for refractory epilepsy.
    Hamandi K; Sander JW
    Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.
    Arroyo S; Anhut H; Kugler AR; Lee CM; Knapp LE; Garofalo EA; Messmer S;
    Epilepsia; 2004 Jan; 45(1):20-7. PubMed ID: 14692903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
    French J; Brandt C; Friedman D; Biton V; Knapp L; Pitman V; Chew M; Dubrava S; Posner HB
    Epilepsia; 2014 Aug; 55(8):1220-8. PubMed ID: 24962242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Pompili A; Carapella CM
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of pregabalin for nonconvulsive seizures and nonconvulsive status epilepticus.
    Swisher CB; Doreswamy M; Husain AM
    Seizure; 2013 Mar; 22(2):116-8. PubMed ID: 23237765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin: preliminary experience in intractable childhood epilepsy.
    Jan MM; Zuberi SA; Alsaihati BA
    Pediatr Neurol; 2009 May; 40(5):347-50. PubMed ID: 19380070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).
    Lossius MI; Hessen E; Mowinckel P; Stavem K; Erikssen J; Gulbrandsen P; Gjerstad L
    Epilepsia; 2008 Mar; 49(3):455-63. PubMed ID: 17888074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.
    Miller R; Frame B; Corrigan B; Burger P; Bockbrader H; Garofalo E; Lalonde R
    Clin Pharmacol Ther; 2003 Jun; 73(6):491-505. PubMed ID: 12811359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS).
    Ryvlin P; Kälviäinen R; Von Raison F; Giordano S; Emir B; Chatamra K
    Eur J Neurol; 2010 May; 17(5):726-32. PubMed ID: 20113339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico).
    Rivera-Castaño L; Leal-Cantu R; Abreu P; Guerrero M; Davila G
    Epilepsy Res; 2012 Jun; 100(1-2):74-9. PubMed ID: 22304935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary observations on the activity of progabide, administered as monotherapy in complex partial seizures.
    Benassi E; Besio G; Bo GP; Cocito L; Maffini M; Mainardi P; Morselli PL; Loeb C
    Int J Clin Pharmacol Res; 1988; 8(5):353-61. PubMed ID: 3068161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.
    Baulac M; Leon T; O'Brien TJ; Whalen E; Barrett J
    Epilepsy Res; 2010 Sep; 91(1):10-9. PubMed ID: 20696552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral pregabalin as an add-on treatment for status epilepticus.
    Novy J; Rossetti AO
    Epilepsia; 2010 Oct; 51(10):2207-10. PubMed ID: 20550551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences with pregabalin in the treatment of focal epilepsies].
    Gil-Nagel Rein A; Gómez-Alonso J
    Rev Neurol; 2005 May 16-31; 40(10):609-13. PubMed ID: 15926135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.